Advances in Pancreatic Cancer Diagnosis and Treatment
Pancreatic cancer arises when cells in the pancreas, a glandular organ behind the stomach, begin to multiply out of control and form a mass. These cancerous cells have the ability to invade other parts of the body. There are a number of types of pancreatic cancer. The most common, pancreatic adenocarcinoma, accounts for about 90% of cases, and the term "pancreatic cancer" is sometimes used to refer only to that type. These adenocarcinomas start within the part of the pancreas which makes digestive enzymes. Several other types of cancer, which collectively represent the majority of the non-adenocarcinomas, can also arise from these cells. One to two percent of cases of pancreatic cancer are neuroendocrine tumors, which arise from the hormone-producing cells of the pancreas. These are generally less aggressive than pancreatic adenocarcinoma. Signs and symptoms of the most-common form of pancreatic cancer may include yellow skin, abdominal or back pain, unexplained weight loss, light-colored stools, dark urine, and loss of appetite. There are usually no symptoms in the disease's early stages, and symptoms that are specific enough to suggest pancreatic cancer typically do not develop until the disease has reached an advanced stage. By the time of diagnosis, pancreatic cancer has often spread to other parts of the body. In the present book, fifteen typical literatures about Pancreatic cancer published on international authoritative journals were selected to introduce the worldwide newest progress, which contains reviews or original researches on Pancreatic cancer. We hope this book can demonstrate advances in Pancreatic cancer as well as give references to the researchers, students and other related people.
Components of the Book:
  • Chapter 1
    What questions are most important to pancreatic cancer patients soon after diagnosis? A multicenter survey
  • Chapter 2
    Consensus guidelines for diagnosis, treatment and follow-up of patients with pancreatic cancer in Spain
  • Chapter 3
    Surgeons’ knowledge regarding the diagnosis and management of pancreatic cancer in China: a cross-sectional study
  • Chapter 4
    Impact of the treatment of pancreatic exocrine insufficiency on survival of patients with unresectable pancreatic cancer: a retrospective analysis
  • Chapter 5
    Extracellular and intracellular microRNAs in pancreatic cancer: from early diagnosis to reducing chemoresistance
  • Chapter 6
    Untypical autoimmune pancreatitis and pancreatic cancer: differential diagnosis experiences extracted from misdiagnose of two cases
  • Chapter 7
    Surgery for elderly patients with resectable pancreatic cancer, a comparison with non-surgical treatments: a retrospective study outcomes of resectable pancreatic cancer
  • Chapter 8
    Invasive treatment of pain associated with pancreatic cancer on different levels of WHO analgesic ladder
  • Chapter 9
    Volume matters in the systemic treatment of metastatic pancreatic cancer: a population-based study in the Netherlands
  • Chapter 10
    SEOM Clinical Guideline for the treatment of pancreatic cancer (2016)
  • Chapter 11
    The impact of immunotherapy on the survival of pancreatic adenocarcinoma patients who received definitive surgery of the pancreatic tumor: a retrospective analysis of the National Cancer Database
  • Chapter 12
    Differential secretome of pancreatic cancer cells in serum-containing conditioned medium reveals CCT8 as a new biomarker of pancreatic cancer invasion and metastasis
  • Chapter 13
    Searching for novel multimodal treatments in oligometastatic pancreatic cancer
  • Chapter 14
    Exploring the patient experience of locally advanced or metastatic pancreatic cancer to inform patient-reported outcomes assessment
  • Chapter 15
    Pancreatic cancer and depression: myth and truth
Readership: Students, academics, teachers and other people attending or interested in Pancreatic Cancer Diagnosis and Treatment
Saber Amin
Saber Amin, Department of Radiation Oncology, University of Nebraska Medical Center, Nebraska Medical Center, Omaha, USA

Jane Meza
Jane Meza, Department of Biostatistics, College of Public Health, University of Nebraska Medical Center, Omaha, USA

Bing Song
Bing Song, Cardiff Institute of Tissue Engineering and Repair, School of Dentistry, Cardiff University, Cardiff, UK

Amol Narang
Amol Narang, Department of Radiation Oncology and Molecular Radiation Sciences, Johns Hopkins University, Baltimore, USA

Helen Kitchen
Helen Kitchen, DRG Abacus, Clinical Outcomes Assessment, Manchester, UK

Mary Hodgin
Mary Hodgin, Department of Surgery, Advanced Practice Nursing, Johns Hopkins University, Baltimore, MD, USA

and more...
Copyright © 2006-2024 Scientific Research Publishing Inc. All Rights Reserved.
Top